antibody

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1)

MBS395611

0.1 mg

650 USD

polyclonal

domestic rabbit

nonconjugated

ELISA, enzyme immunoassay

Antibody

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1)

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1)

neuraminidase

Polyclonal

IgG

Rabbit

Human

470

Purified by immunoaffinity chromatography

Supplied as a liquid in PBS, 0.02% sodium azide.

May be stored at 4 degree C

ELISA (EIA)

Immunogen: Synthetic peptide corresponding to the neuraminidase protein from seasonal Influenza A/Georgia/20/2006 (H1N1) (Genbank accession no. ACA33620)

Antigen Immunoaffinity Purified Polyclonal

nfluenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong (3). There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low (4). Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus (5).

168827347

ACA33620

0.1 mg

650 USD